Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Ginger & Pregnancy Botanicals

The Herbal Tea Aisle, Sorted by Evidence

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

12 human trials, about 41 studies, Ginger: many RCTs; most other herbs: limited data. The written rationale for this grade is still being prepared.

FDA
Botanicals are regulated as dietary supplements; not pregnancy-tested for approval
WADA
Not prohibited

Reference only. Not medical advice.

What can go wrong

The core problem with botanicals in pregnancy is unpredictability. Dose and active-compound content vary between products and even between batches of the same product, some herbs affect drug-metabolizing enzymes, and several are documented uterine stimulants that can provoke contractions. For ginger specifically, one review flagged caution close to labor or in anyone with a history of miscarriage, vaginal bleeding, or clotting disorders because of a theoretical bleeding risk, and doses much above about 1,000 mg per day are not well studied. Raspberry leaf is commonly avoided in the first trimester on theoretical grounds. Some herbs, including blue cohosh, black cohosh, and pennyroyal, are avoided entirely in pregnancy. Because pregnant people often take herbs without mentioning them, this is not self-diagnosis territory: decisions about any herbal product, and any nausea severe enough to affect eating or hydration, belong with an obstetric provider or midwife, who can weigh them against your own history.

Herbal products are used widely in pregnancy, with surveys reporting a quarter to two thirds of pregnant women taking at least one, ginger, raspberry leaf, and chamomile most often. The evidence behind them varies enormously. Ginger is the most-studied and is supported by a dozen randomized trials for nausea, with an effect comparable to vitamin B6 and no signal of increased malformations at typical doses. Peppermint and lemon balm are generally considered likely safe in moderation, while red raspberry leaf rests mostly on tradition and a single small trial. Chamomile and fennel fall into the insufficient-data category, and a handful of herbs are documented uterine stimulants that are avoided in pregnancy. The steady message from ACOG and from the Cochrane reviewers is that no herbal product should be taken in pregnancy without a provider's input, because potency and active-compound content shift from batch to batch.

The pregnancy-tea aisle ranges from genuinely evidence-backed (ginger) to traditional-but-unproven to better avoided, and the labels rarely tell you which is which.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Ginger: easing nausea of pregnancy, the one botanical here with repeated randomized support
  • Peppermint and lemon balm: settling mild nausea and digestive discomfort, likely safe in moderation
  • Red raspberry leaf: traditional late-pregnancy tonic, weak evidence, often reserved for the second and third trimester
  • General comfort measures within provider-guided limits, with severe or persistent nausea referred for medical care

What people get wrong

  • Often said"Natural" herbal teas are automatically safe in pregnancy.

    ActuallyNatural does not mean safe. Herbs carry active compounds, and several documented ones, including blue cohosh, black cohosh, and pennyroyal, act as uterine stimulants linked to contractions, miscarriage, or fetal harm. Potency also shifts batch to batch. Some herbs are fine in moderation, some are unproven, and some are avoided outright.

  • Often saidAll pregnancy teas are basically the same.

    ActuallyThey are not. Ginger has real trial evidence for nausea and an effect comparable to vitamin B6; peppermint and lemon balm are likely safe in moderation; raspberry leaf is traditional and rests on one small trial; chamomile and fennel have insufficient data. A single blend labeled "pregnancy tea" can contain any mix of these.

  • Often saidGinger works better than the standard nausea options, so it can replace them.

    ActuallyThe trials do not show that. Across four RCTs in 625 women ginger was no different from vitamin B6, and ACOG lists B6 with or without doxylamine as first-line while placing ginger among nonpharmacologic options. Ginger is a reasonable comfort measure, not a substitute for medical management of severe nausea or hyperemesis, which needs a provider.

Who profits, and who pushes back

  • Ginger randomized-trial literature

    endorsesMost-studied pregnancy botanical

    Ginger below 1,000 mg per day can relieve nausea and even hyperemesis symptoms without increasing adverse effects for the woman or fetus; it is the one herb with solid supporting data.

  • Midwifery and herbal tradition

    caveatsPractitioners, red raspberry leaf

    Red raspberry leaf is valued as a uterine tonic and birth preparation, typically recommended only from the second or third trimester, with caution about earlier use and contraction risk.

  • Natural Medicines Database / APA

    mixedEvidence-rating reference

    Chamomile, fennel, and several popular pregnancy herbs are rated as having insufficient reliable information for safety, despite frequent use and recommendation.

  • ACOG

    cautionsUS obstetric authority

    No herbal supplement should be taken during pregnancy without consulting a provider; botanical pharmacokinetics vary even batch to batch, which can alter uterine activity.

Where the research comes from

Most of the published research on this comes from one place. 55% of it is from High herbal use regions. Findings that no unrelated group has reproduced are weaker than the study count makes them look.

Share of published research by country of origin.
PlaceShare of published research
High herbal use regions55%
Lower use45%

Research published from: Global.

How we got here

Herbal care in pregnancy reaches back centuries across many peoples. Ginger has a long place in Chinese, Ayurvedic Indian, and broader Asian medicine, where it was used for digestive complaints and nausea long before Western trials examined it, and it spread through Arab and East African trade routes into wider global use. Raspberry leaf and nettle belong to older European and North American folk traditions as pregnancy tonics. Formal research arrived late and unevenly: controlled trials clustered around ginger through the 2000s and 2010s and built a genuine evidence base for nausea, while most other herbs stayed understudied, leaving traditional reputation and modern data out of step. Cross-country surveys in Australia, Switzerland, Spain, and Bangladesh have since documented high and frequently undisclosed use, which has prompted calls for both better trials and franker conversation between patients and providers.

  1. CenturiesGinger used for nausea in Chinese, Ayurvedic, and wider Asian medicine; raspberry leaf a European and North American pregnancy tonic
  2. 2001Simpson randomized trial of raspberry leaf in 192 Australian women finds no clear benefit and no clear harm
  3. 2005Trial and appraisal report ginger equivalent to vitamin B6 for reducing nausea and vomiting in pregnancy
  4. 2014Viljoen meta-analysis of 12 RCTs (1,278 women) confirms ginger improves nausea versus placebo
  5. 2014Cochrane review of 41 trials (5,449 women) finds low-quality evidence and no strong support for any single NVP intervention
  6. 2018ACOG Practice Bulletin 189 names vitamin B6 with or without doxylamine as first-line and lists ginger as a nonpharmacologic option
  7. 2020sSurveys across several countries document high, often-undisclosed herbal use and call for disclosure

At a glance

Ginger for nausea
< 1,000 mg/day
Likely safe
Ginger, peppermint, lemon balm
Use with caution
Red raspberry leaf
Insufficient data
Chamomile, fennel

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Ginger & Pregnancy Botanicals. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources